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Abstract
Tuberculosis remains a major health threat and its control depends on improved measures of prevention, diagnosis and
treatment. Biosignatures can play a significant role in the development of novel intervention measures against TB and blood
transcriptional profiling is increasingly exploited for their rational design. Such profiles also reveal fundamental biological
mechanisms associated with the pathology of the disease. We have compared whole blood gene expression in TB patients,
as well as in healthy infected and uninfected individuals in a cohort in The Gambia, West Africa and validated previously
identified signatures showing high similarities of expression profiles among different cohorts. In this study, we applied a
unique combination of classical gene expression analysis with pathway and functional association analysis integrated with
intra-individual expression correlations. These analyses were employed for identification of new disease-associated gene
signatures, identifying a network of Fc gamma receptor 1 signaling with correlating transcriptional activity as hallmark of
gene expression in TB. Remarkable similarities to characteristic signatures in the autoimmune disease systemic lupus
erythematosus (SLE) were observed. Functional gene clusters of immunoregulatory interactions involving the JAK-STAT
pathway; sensing of microbial patterns by Toll-like receptors and IFN-signaling provide detailed insights into the
dysregulation of critical immune processes in TB, involving active expression of both pro-inflammatory and
immunoregulatory systems. We conclude that transcriptomics (i) provides a robust system for identification and validation
of biosignatures for TB and (ii) application of integrated analysis tools yields novel insights into functional networks
underlying TB pathogenesis.
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Introduction
Tuberculosis (TB), caused by the intracellular bacterium
Mycobacterium tuberculosis (Mtb), remains a major health threat.
Frequently infection remains latent with a 10% lifetime risk of
developing active TB disease. Current tools for prevention,
diagnosis and treatment are inadequate, and despite the use of
Bacille Calmette-Gue ´rin (BCG) as vaccine to prevent TB, its
efficacy and application practices varies worldwide [1].
Global gene transcript profiling in peripheral blood leukocytes
(PBL) has evolved into a state-of-the-art measure of the status of
the immune system in health and disease (reviewed in [2]).
Immune cells patrol the human macroorganism and circulate
through blood and lymph to relocate to different tissue sites in the
body. During infection, alterations of immune processes in the
infected tissue lead to changes in the transcriptional profiles of
circulating immune cells. These changes in host gene expression
reflect the response of the host immune system to invading
pathogens.
Although gene expression profiling of PBL from Mtb-infected
individuals has been limited, transcriptional signatures character-
istic for latent infection and active disease are slowly emerging
[3–6]. These gene signatures have already provided proof of
principle for development of novel TB diagnostics by reliably
discriminating Mtb latently infected healthy individuals from
patients with active TB disease. The ultimate goal herein will be
the risk assessment in latently Mtb-infected individuals for
progression to active disease. Such disease-related signatures can
also be exploited for monitoring of vaccine and drug trials by
providing surrogates that predict clinical outcome at early stages of
trials [7,8].
Previous studies focusing on gene signatures indicative of TB
disease versus latent infection [3,5,6,9] have revealed several
clusters of differentially regulated genes including genes involved
in type I and II interferon (IFN) signaling, cell type-specific
signatures such as increased NK cell and neutrophil activity [5,6],
involvement of RAB33A and SOCS3 in T cells [9,10], and markers
of apoptosis [6]. In this study, we identify new and validate
previously identified gene signatures in TB in an independent
cohort from The Gambia and use a unique combination of
classical gene expression, pathway, and functional association
analyses integrated with intra-individual expression correlations
for identification of transcriptionally regulated markers of key
biological processes in TB.
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Identification of differentially expressed genes
We interrogated the transcriptomes of PBL from TB patients
(TB) and healthy donors who were latently infected (LTBI) or
uninfected with Mtb (NID) to validate previous findings in an
independent cohort and to define pathognomonic markers of TB.
Group-wise comparisons revealed a total of 1,661 differentially
expressed genes between TB and LTBI (log2-fold change M.0.5
or M,20.5; significance q,0.01). No obvious differences were
observed between LTBI and NID when applying the same
stringent cutoff values. Less stringent filtering did show significant
differences between these two cohorts, although with weak
differences in fold changes. Consequently, we focused on TB
versus LTBI comparisons, with emphasis on functional pathways
and interaction networks to gain novel insight into biological
processes relevant for TB protection and pathogenesis.
Differentially expressed genes between TB and LTBI showed a
highly significant enrichment of genes involved in regulation of
defense and immune responses, signal transduction and activation
of leukocyte populations. A full list of enriched gene sets based on
gene ontology (GO) terms using the web-based tool GOrilla [11] is
provided as supplemental information (Table S1).
SPIA analysis of TB versus LTBI
In an attempt to integrate differentially expressed genes into
known biological pathways, we performed a signaling pathway
impact (SPIA) analysis on our microarray data in this Gambian
cohort. This analysis combines canonical enrichment analysis with
a novel type of evidence that measures perturbation within a given
pathway [12]: The x-axis depicts enrichment of gene sets based on
GO descriptions; the y-axis visualizes perturbation of genes
involved in 89 well-characterized KEGG (Kyoto Encyclopedia
of Genes and Genomes) pathways. In this perturbation, differen-
tially expressed genes in a higher hierarchical position within a
certain pathway have higher impact on the outcome of the
analysis. Simultaneously, this analysis takes into account known
influences of any gene within the KEGG pathway on the
expression of downstream genes. Focusing on the identification
of activated pathways in TB, we performed an exploratory analysis
of the top 1.000 upregulated genes (representing genes with a log2-
fold change of M.0,5) in TB versus LTBI (Figure 1). This
somewhat arbitrary cutoff was chosen to allow a sufficient input
number of genes for the perturbation analysis, and at the same
time not to weaken the gene enrichment analysis with a large input
of genes showing only marginal levels of upregulation.
This SPIA analysis revealed a remarkable enrichment of genes
involved in the autoimmune disease systemic lupus erythematosus
(SLE). This enrichment of differentially expressed genes is mainly
dominated by the involvement of increased histone expression in
TB. Other KEGG pathways with significantly enriched gene sets
in The Gambian cohort involved components of the complement
and coagulation cascades, TLR signaling and, to a lesser degree,
cytokines and their homologous receptors. Differential expressions
between TB and LTBI in The Gambian cohort for all genes in
these pathways are depicted in Table S2.
Figure 1. SPIA analysis on differentially expressed genes. Analysis was run on the top 1.000 ranking genes showing increased expression in
TB compared to LTBI . X-axis indicates enrichment of genes; y-axis represents perturbation of genes within pathways. Pathways above the blue line
are significant at 5% after FDR correction, those above the red lines at 5% after Bonferroni correction.
doi:10.1371/journal.pone.0026938.g001
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perturbation within the Fc gamma receptor-mediated phagocyto-
sis pathway. Figure 2 illustrates the complete KEGG pathway for
Fc gamma receptor-mediated phagocytosis with coloring, permit-
ting visualization of the differential expression of genes involved.
Correlations in gene expression
Biological variation between individuals within each group
could obscure expression differences of relevant genes. We
therefore analyzed gene expression levels and correlations between
genes in single individuals, irrespective of fold changes and
significance values in the group-wise comparisons. We chose
FCGR1 as starting point for correlation analyses as one of the most
differentially expressed genes in both African cohorts (The
Gambia and South Africa), which also showed strongest
discriminatory power for expression profiles of TB patients and
LTBI donors (data not shown). Figure 3 illustrates expression
correlations between FCGR1 and several highly significantly
correlated genes. A list of the top 100 best correlated genes, both
positively and negatively, is provided as supplementary material
(Table S3). In contrast to group-wise comparisons, these plots
demonstrate correlations in expression levels between genes in
individuals from each group. While expression levels of these
exemplary genes discriminate between TB and LTBI, they also
indicate biological variation leading to a degree of overlap between
groups. In contrast, expression levels between LTBI and NID were
not significantly different, neither by group-wise comparisons nor
by gene correlation analysis. Intriguingly, in two individuals of the
TB group, gene expression signatures resembled profiles charac-
teristic for the LTBI and NID groups. It remains to be established
why these individuals displayed a signature similar to healthy
individuals, since clinical diagnosis by consecutive sputum smear-
positive tests unequivocally grouped these individuals in the active
TB group.
Functional correlation of differentially expressed genes
Correlations of differentially expressed genes between TB and
LTBI, at least in part, may reflect differences in cell type
composition between individuals in either group. In an attempt to
elucidate the functional relevance of this biological variation, we
analyzed 200 genes that showed highest expression correlation
with FCGR1 (top 100 highest positive and top 100 highest negative
correlations). Functional association analysis of these genes using
the manually curated STRING database [13] identified a network
of 71 gene products (Figure 4); a high resolution version is also
provided as supplementary material (Figure S1) with highly
interacting gene products centered around the JAK-STAT
pathway (STAT1, SOCS3; previously also shown in the South
African cohort [9]), ICAM1, TLRs, Fc gamma receptors,
complement factors and IFN-response genes. The full list of these
interacting genes with their respective differential expression
between TB and LTBI is provided as supplementary material
(Table S4; sheet 1). Some of these correlating genes (FBXO16,
TNFRSF10 and TNFRSF17) expressed poor q-values in the group-
Figure 2. KEGG pathway of Fc gamma receptor-mediated phagocytosis. Items colored red and green indicate respectively up- and down-
regulated genes in TB as compared to LTBI (light-to-dark colors indicate medium to high differential expression); yellow indicates clusters of genes
including both up- and down-regulated genes. Figure was recreated and modified based on KEGG pathway hsa0466 (http://www.genome.jp/kegg/
pathway/hsa/hsa04666.html).
doi:10.1371/journal.pone.0026938.g002
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tions and the potential risk of dismissing relevant genes due to
biological variation within single groups and cohorts. In a final
analysis we assessed functional relations of genes within this
network. To this end, a functional annotation analysis of the 71
genes within this functional interaction network was performed
using the online tool DAVID [14]. Results of this functional
annotation demonstrated profound associations within this
network of genes involved in immune inflammatory responses,
apoptosis, responses to bacterial molecular patterns and the NF-
kappa B cascade (see Table S4; sheet 2).
Validation of previously identified expression profiles
Previous studies by our group [3,6], identified gene profiles
which discriminated between TB and LTBI, including a group of
interferon (IFN)-inducible genes, which were markedly upregu-
lated in TB patients. A recent publication by another group [5]
described a whole-blood transcription signature in TB patients
dominated by a neutrophil-driven IFN-inducible gene profile,
consisting of both IFN-c and type I IFN-ab signaling. For
validation purposes, we compared these signatures (cohort UK),
with expression profiles from cohorts in South Africa (SUN;
published in [6]) and The Gambia (MRC; described here).
Figure 5 depicts comparisons between the three different
cohorts, showing statistically significant differences in gene
expression between TB and LTBI. As many as 92% of the genes
within the TB signature and 96% of the IFN-inducible gene
signature identified in the UK cohort [5] did show significant (at
q,0.05) differential expression between TB and LTBI in either
one or both of the African cohorts. A full list of matching gene IDs
and expression data from both gene profiles is provided as
supplementary material (Table S5). Thus transcriptomics allows
robust correlation of distinct clusters of differentially expressed
genes among cohorts from different geographical locations and
ethnic origins.
Discussion
Current diagnostics for TB are inaccurate and slow, underlining
the urge for better and swifter measures [15]. New strategies
should aim at developing a point-of-care test for TB [16]. In
addition to tests that rely on identifying Mtb or its products, host
genetic profiles provide a valuable source for the development of
new diagnostic tools. Such host profiles can also provide in-depth
insights into functional mechanisms of protection and pathogenesis
in TB. Rational design of a host biosignature for TB should
include elucidation of the relationship of differentially expressed
genes within functional clusters and requires validation of
candidate biomarker genes and signatures [7,17]. Our analysis
reveals a group of differentially expressed genes which (i) perform
relevant biological functions in TB and (ii) are shared in different
populations and identified by different analytical systems. Hence,
the identification of new TB-related gene expression profiles and
validation of previously identified signatures herein, represents a
valuable contribution towards pathogenesis-based transcriptomic
diagnosis of TB.
During pulmonary infection with Mtb, different immune
processes are induced in the affected tissue and are accompanied
by infiltration of immune cells. These alterations are succeeded by
changes in the gene expression profile of re-circulating immune
cells in the peripheral blood. Due to their easy accessibility,
peripheral blood leukocytes have become the preferred surrogate
targets for analyzing disease-related biomarkers in TB patients and
LTBI due to their easy accessibility. Previous studies on gene
transcription profiling in peripheral blood cells of TB patients have
identified signatures of differentially expressed genes [3–6,9]. Our
demonstration of highly similar signatures and the identification of
new profiles represents a major step forward towards true
biosignatures for TB. Validation of several of these signatures
across cohorts from different geographical locations and ethnical
background, identified by independent research groups using
different platforms and analytical methods, demonstrates robust-
ness of these biomarker signatures.
Our analysis of expression profiles focused on functional
pathways and interaction networks to gain in-depth insights into
biological processes underlying protection and pathogenesis in TB.
Signaling pathway impact analysis (SPIA) of the top 1,000 most
differentially expressed genes between TB and LTBI revealed an
unexpected enrichment of genes that are involved in SLE. This
systemic autoimmune disease is characterized by deposition of
immune complexes (IC) and a gene expression profile of elevated
type I IFN signaling [18,19] similar to what was observed in TB
(this study and [5,6]). The causes of this elevated type I IFN
expression in SLE are likely deposition of ICs triggering IFNa
production by plasmacytoid dendritic cells through Fc gamma
receptors [19]. Elevated levels of IC accompanied by defective IC
solubilization has also been documented in serum of TB patients
[20] and may account, at least in part, for the similarities in gene
signatures observed in both diseases. Reduced solubilization of IC
also has a well-known pathological manifestation in leprosy,
notably during malignant stages [21], which is caused by the
mycobacterial pathogen M. leprae. The observed increased
expression of TLRs as described here, as key molecules in type I
Figure 3. Correlations of gene expression in cohort subjects. Genes showing a highly significant correlation of expression with FCGR1 in all
subjects in the Gambian cohort. Red dots indicate expression levels in TB patients, blue in LTBI and green of NID donors. X and Y axes represent
normalized expression levels of individual genes.
doi:10.1371/journal.pone.0026938.g003
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top 100 positively correlated, plus the top 100 negatively correlated genes. Shown here is the confidence view.
doi:10.1371/journal.pone.0026938.g004
Figure 5. Comparison of differential expression in three independent cohorts. Comparison of differential gene expression between TB and
LTBI in cohorts in South Africa (SUN) and The Gambia (MRC) with gene profiles in a cohort in the United Kingdom (UK) identified by Berry, et al. (Berry
2010). Significance of differential expression at corrected p-value level of q,0.05.
doi:10.1371/journal.pone.0026938.g005
Functional Gene Expression Signatures in TB
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e26938IFN signaling, likely further contributes to the IFN-inducible gene
signature observed in both SLE and TB.
In the cohort from The Gambia described herein, the gene
FCGR1 evolved as one of the strongest differentially expressed
genes between TB and LTBI, with the highest discriminative
power between the two groups. This is in accordance with our
previous observations in other cohorts, namely from Europe and
South Africa [3,6]. Upregulated expression of FCGR1 in TB
patients followed by alterations in downstream pathways are a
clear hallmark of active TB disease, as identified through SPIA
analysis (Figure 2) and analysis of differential gene expression
patterns involved in the KEGG pathway of Fc gamma receptor-
mediated phagocytosis (Figure 3).
A confounding aspect when studying gene expression profiles in
many diseases including TB is the inherent biological variation
between individuals within study populations, which is most
pronounced in the active TB group. An intriguing example for this
variation is the identification of two patients in the cohort
described herein, which displayed an expression signature that
closely resembled that of healthy individuals. Expression levels of
correlating genes in figure 4 and a heatmap provided as
supplementary material (Figure S2) illustrate these ‘‘outliers’’.
Although we cannot formally exclude that the two outlier TB
patients in this study were diseased from non-tuberculous
mycobacteria, from a clinical perspective this is unlikely in a
cohort of HIV-negative individuals, where non-tuberculous
disease cases are uncommon. Previous studies have speculated
about outliers within the LTBI group with a signature indicative of
active TB as sub-clinical active cases [5] or individuals progressing
to active TB before the onset of clinical symptoms [4]. Our
findings revealing outliers in the active TB group with a signature
characteristic of the healthy groups emphasize the occurrence of
outliers as a general phenomenon in all groups and hence caution
is advised on speculating about their prognostic value before
definite proof has been obtained. Reliable interpretation will
depend on data from longitudinal follow-up studies such as LTBI
who progress into active TB disease as well as of cured TB patients
with or without relapses.
When analyzing group-wise comparisons, variations amongst
individual group members can obscure disease-related markers
and profiles, which prompted us to embark on further analyses of
correlations in gene expression among individuals of the different
groups. Taking FCGR1 as the starting point for these analyses, a
large group of genes was identified that revealed both positive and
negative correlations with FCGR1 expression. In part, these
correlations also reflect differences in cell type compositions
between subjects, which inherently contribute to inter-individual
variation. Biological association analysis of 200 genes with the
highest expression correlation (both positive and negative) revealed
a network of highly interrelated gene products. Three genes within
this functional network had a very poor significance value (q.0.1)
in a group-wise comparison between TB and LTBI, underlining
the power of analyzing gene expression correlations and the
potential risk of dismissing relevant genes due to biological
variation within groups. Functional annotation analysis of the
genes in this network indicated strong association with immune
inflammatory responses, apoptosis, responses to bacterial molec-
ular patterns and the NF-kappa B cascade. Central to this network
are pro-inflammatory regulators with interactions involving the
JAK-STAT pathway – STAT1, SOCS3; previously also shown in
the South African cohort [9] – ICAM1, TLRs, Fc gamma
receptors and complement factors and IFN-response genes.
Elevated expression in TB patients of IFN-related genes, TLRs
and genes involved in the JAK-STAT signaling pathway (STAT1,
OSM and NMI) at first sight seems contradictory to the increased
expression of SOCS3, known to inhibit signal transduction
emanating from cytokine and TLR stimulation through the
JAK-STAT pathway [22,23]. In a similar way, our data indicate
exacerbated expression of complement factors, despite increased
expression of the complement cascade silencing molecule SERP-
ING1 [24]. These findings indicate the activation of inhibitory
feedback loops in presence of respective activating signaling
cascades. Future studies are needed to clarify whether these
feedback loops effectively participate in fine-tuning of effector
cascades or are activated in vein in TB.
Blood transcript profiling is emerging as a common tool for
understanding the status of the human immune response during
systemic and infectious diseases [2]. Here we describe the
identification of new pathogenesis-driven gene expression signa-
tures and validation of previously identified gene profiles from
other cohorts in TB. We have focused on functional pathways and
interaction networks to gain in-depth insights into biological
processes relevant to protection and pathogenesis in TB which can
be harnessed for relevant biomarker signatures. Altered expression
of genes in these biological pathways provides a deeper insight into
the dysregulation of key regulatory immune processes in the
progression from LTBI to TB disease.
Together these results provide a better understanding of the
immune pathology in TB, while combined biosignatures may be
employed into the development of a pathogenesis-based point-of-
care test.
Methods
Ethics statement
The study presented here was approved by the Gambia
Government/Medical Research Council Joint Ethics Committee
in The Gambia and by the Ethical committee 1 on Campus
Charite – Mitte in Berlin, Germany. Written informed consent
was obtained from all study participants.
Subject enrolment and sample collection
In this study, a total of 46 sputum smear and chest x-ray positive
TB patients (TB), 25 latently infected healthy donors (LTBI, TB
case contacts with Mantoux test induration .=10 mm) and 37
uninfected donors (NID, Mantoux test induration =0 mm) were
included from a cohort recruited at the Medical Research Council
Laboratories (MRC) in Banjul, The Gambia. All subjects were
HIV
– and samples from TB patients were taken prior to
chemotherapy. General characteristics of the study subjects in
this cohort are given in Table 1. From every donor, 2.5 ml of
peripheral whole blood was collected in PAXgene tubes
(PreAnalytix) and stored at 280uC prior to processing.
RNA extraction and microarray procedure
Extraction and processing of RNA were performed as described
previously [6]. Briefly, RNA was extracted using the PAXgene
Blood RNA Kit (PreAnalytix) and labeled with the Fluorescent
Linear Amplification Kit (Agilent Technologies) according to
manufacturer’s instructions. Quantity and labeling efficiency were
verified before hybridization of the samples to whole-genome
4644 k human expression arrays (Agilent) and scanned at 5 mm
using an Agilent scanner.
Data analysis
Analysis of the scanned images was performed with Feature
Extraction software (version 6.1.1, Agilent Technologies). Data
analysis was performed using the R package. Data were log-
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based on log2 fold changes (M-values) in average gene expression
with a q value ,0.01 (q equals the p value corrected for multiple
testing). Microarray data are in compliance to MIAME guidelines
and have been deposited in the GEO database under accession
GSE28623.
Bio-statistical analysis
Enrichment analysis of differentially expressed genes based on
Gene Ontology terms was performed using the web-based tool
GOrilla (http://cbl-gorilla.cs.technion.ac.il) [11]. Signaling path-
way impact analysis (SPIA), combining classic gene enrichment
and pathway perturbation was performed using an implemented R
package [12]. Functional association studies were performed using
the manually curated STRING database (online interface
available under http://string-db.org) [13] and functional annota-
tion of genes in networks was performed using the web-based tool
DAVID (http://david.abcc.ncifcrf.gov) [14].
Supporting Information
Figure S1 Functional association network of FCGR1
correlating genes. STRING network showing functional
associations between FCGR1-correlated genes (high-resolution
version of Figure 4).
(PNG)
Figure S2 Heatmap of differentially expressed genes.
Indicated are the 50 most differentially expressed genes between
TB patients and healthy donors (TST_Neg and TST_Pos). TB
patients with expression patterns similar to healthy individuals are
outlined. Normalized expression levels are colored blue to red (low
to high expression resp.).
(PNG)
Table S1 Gene Ontology enrichment of differentially
expressed genes. Enrichment analysis of genes differentially
expressed between TB and LTBI was performed using the
DAVID bioinformatics tool (Huang 2009).
(XLS)
Table S2 KEGG pathway genes identified by SPIA
analysis. Full lists of genes in the pathways identified in the
SPIA analysis and their differential expression between TB and
LTBI within the cohort from The Gambia. A few gene names
derived from the KEGG pathways could not be identified within
the expression data from our microarray platform. Genes with
significant differential expression between TB and LTBI are
indicated in black; genes with significance values of q.0.05 are
indicated in grey.
(XLS)
Table S3 Genes with expression correlation to FCGR1.
List of the top 100 genes showing strongest positive and negative
correlation with expression of FCGR1 (sheet 1 indicates top 100
positively correlated; sheet 2 top 100 negatively correlated genes).
(XLS)
Table S4 Differential expression and annotation of
genes in STRING network. Genes within the functional
association network depicted in Figure 5 and their differential
expression between TB and LTBI, and correlation with FCGR1.
Sheet 2 shows functional annotation of these genes as analyzed by
the online DAVID tool.
(XLS)
Table S5 Genes within the TB and IFN-inducible
signatures. Lists of genes within the TB signature and interferon
signaling, described for the UK cohort by Berry et al [5] that
match annotations of transcripts in cohorts from The Gambia
(MRC) and South African (SUN). The original 393 transcript TB
signature identified in the UK cohort represented 307 unique gene
IDs, of which 288 matched with annotations in the expression data
from the Gambian and South African cohorts. Indicated are fold
changes on a log2 scale (M) and statistical significance (q) of
differential expression between TB and LTBI. Positive M values
indicate increased expression in TB compared to LTBI.
(XLS)
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